Search

Danping Li

from New York, NY
Age ~41
Get Report
Also known as:
Li Danping
Related to:
Yu C Lin, 77Yujing Li, 31Lin P Szeto, 71David G Lin, 54Mei Lin, 51U Cherng, 44
Connected to:
Abbey Li, 34Abie Li, 44Aifang Li, 57Alanna Li, 30Alvin G Li, 49Anbo Li, 51Anchen Li, 35Antony T Li, 82Baiqi Li, 38Baomei Li, 31

Danping Li Phones & Addresses

  • New York, NY
  • Brooklyn, NY

Resumes

Resumes

Danping Li Photo 1

Member, Principle Cmc Consultant

View page
Location:
New York, NY
Industry:
Pharmaceuticals
Work:
Rib-X Pharmaceuticals, New Haven, CT since Oct 2007
Director
Boehringer Ingelheim, Ridgefield, CT Mar 2005 - Oct 2007
Group leader, Pharmaceutics
Bristol-Myers Squibb, NewBrunswick, NJ Oct 1997 - Mar 2005
Senior Research Investigator
Education:
Wesleyan University, CT 1992 - 1997
Ph.D, Chemistry
Skills:
Formulation
Drug Development
Drug Discovery
Pharmaceutics
Drug Delivery
Hplc
Clinical Trials
Medicinal Chemistry
R&D
Clinical Development
Chemistry
Biotechnology
Pharmaceutical Industry
Lifesciences
Glp
Technology Transfer
Interests:
Sterile Formulation
Formulation Technology
Drug Delivery
Danping Li Photo 2

Danping Li

View page

Publications

Us Patents

Antidiabetic Formulation And Method

View page
US Patent:
7507768, Mar 24, 2009
Filed:
Jan 30, 2007
Appl. No.:
11/668536
Inventors:
Danping Li - East Brunswick NJ, US
Lawan Phusanti - Lafayette NY, US
Divyakant S. Desai - West Windsor NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31/155
A61K 31/425
US Classification:
514635, 514369
Abstract:
An antidiabetic pharmaceutical formulation is provided, especially adapted for treating Type II diabetes, which includes a combination of metformin and glipizide in a manner to control moisture in the formulation so that the glipizide does not hydrolyze, yet the metformin is compressible, if necessary. A method for treating diabetes is also provided employing the above formulation.

Antidiabetic Formulation And Method

View page
US Patent:
20030139461, Jul 24, 2003
Filed:
Dec 17, 2001
Appl. No.:
10/023533
Inventors:
Danping Li - East Brunswick NJ, US
Lawan Phusanti - Princeton NJ, US
Divyakant Desai - West Windsor NJ, US
International Classification:
A61K031/426
A61K031/155
US Classification:
514/369000, 514/635000
Abstract:
An antidiabetic pharmaceutical formulation is provided, especially adapted for treating Type II diabetes, which includes a combination of metformin and glipizide in a manner to control moisture in the formulation so that the glipizide does not hydrolyze, yet the metformin is compressible, if necessary. A method for treating diabetes is also provided employing the above formulation.
Control profile
Danping Li from New York, NY, age ~41 Get Report